|
Volumn 30, Issue 5, 1998, Pages 1967-1968
|
Twelve years of cyclosporine in pediatric heart transplantation: What is the future?
a a a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
ALPHA INTERFERON;
AZATHIOPRINE;
CALCIUM ANTAGONIST;
CREATININE;
CYCLOSPORIN;
CYCLOSPORIN A;
DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;
LYMPHOCYTE ANTIBODY;
METHOTREXATE;
STEROID;
ADOLESCENT;
AGED;
CHILD;
CONFERENCE PAPER;
DRUG BLOOD LEVEL;
FOLLOW UP;
GRAFT REJECTION;
HEART DISEASE;
HEART TRANSPLANTATION;
HUMAN;
HYPERTENSION;
IMMUNOSUPPRESSIVE TREATMENT;
INFANT;
INTRAVENOUS DRUG ADMINISTRATION;
MAJOR CLINICAL STUDY;
MICROEMULSION;
NEWBORN;
ORAL DRUG ADMINISTRATION;
PEDIATRIC SURGERY;
PRIORITY JOURNAL;
SURVIVAL;
ADOLESCENT;
AZATHIOPRINE;
CARDIOMYOPATHIES;
CHILD;
CHILD, PRESCHOOL;
CYCLOSPORINE;
DRUG THERAPY, COMBINATION;
FOLLOW-UP STUDIES;
HEART DEFECTS, CONGENITAL;
HEART TRANSPLANTATION;
HUMANS;
IMMUNOSUPPRESSION;
IMMUNOSUPPRESSIVE AGENTS;
INFANT;
INFANT, NEWBORN;
KIDNEY FAILURE, CHRONIC;
KIDNEY TRANSPLANTATION;
METHOTREXATE;
REOPERATION;
RETROSPECTIVE STUDIES;
STEROIDS;
SURVIVAL RATE;
TIME FACTORS;
|
EID: 0031661725
PISSN: 00411345
EISSN: None
Source Type: Journal
DOI: 10.1016/S0041-1345(98)00498-9 Document Type: Conference Paper |
Times cited : (1)
|
References (11)
|